Most of the studies focused on elucidating the anti-cancer mechanisms such as apoptosis induction, angiogenesis inhibition, drug resistance reduction by targeting NF-κB and/or STAT3 [18, 27–29]. This evidence concerns the gene STAT3 and cancer.